Cadence Capital Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	$493K	Sell	26,900 -88,409	-77%	-$1.62M	0.12%	138
2020 Q2	$2.06M	Buy	115,309 +4,815	+4%	+$86K	0.3%	77
2020 Q1	$1.79M	Sell	110,494 -5,718	-5%	-$92.7K	0.3%	77
2019 Q4	$2.09M	Sell	116,212 -13,780	-11%	-$248K	0.23%	120
2019 Q3	$2.63M	Buy	+129,992	New	+$2.63M	0.37%	81